Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

Satu Koivula; Minna Taskinen; Ping Chen; Harald Holte; Jan Delabie; Marja Liisa Karjalainen Lindsberg; Magnus Bjorkholm; Oystein Fluge; Lars Moller Pedersen; Mats Jerkeman; Mikael Eriksson; Sampsa Hautaniemi; Sirpa Leppa

Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

Satu Koivula, Minna Taskinen, Ping Chen, Harald Holte, Jan Delabie, Marja Liisa Karjalainen Lindsberg, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppa

Breastcancer-genetics

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Pages (from-to)	1281-1281
Journal	Blood
Volume	116
Issue number	21
Publication status	Published - 2010
Event	52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando, FL Duration: 2010 Dec 4 → 2010 Dec 7

Subject classification (UKÄ)

Hematology

Cite this

Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Lindsberg, M. L. K., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S., & Leppa, S. (2010). Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study. Blood, 116(21), 1281-1281.

Koivula, Satu ; Taskinen, Minna ; Chen, Ping et al. / Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study. In: Blood. 2010 ; Vol. 116, No. 21. pp. 1281-1281.

@article{a88db225f704402694f1b13b30741621,

title = "Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study",

author = "Satu Koivula and Minna Taskinen and Ping Chen and Harald Holte and Jan Delabie and Lindsberg, {Marja Liisa Karjalainen} and Magnus Bjorkholm and Oystein Fluge and Pedersen, {Lars Moller} and Mats Jerkeman and Mikael Eriksson and Sampsa Hautaniemi and Sirpa Leppa",

year = "2010",

language = "English",

volume = "116",

pages = "1281--1281",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "21",

note = "52nd Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 04-12-2010 Through 07-12-2010",

}

Koivula, S, Taskinen, M, Chen, P, Holte, H, Delabie, J, Lindsberg, MLK, Bjorkholm, M, Fluge, O, Pedersen, LM, Jerkeman, M , Eriksson, M, Hautaniemi, S & Leppa, S 2010, 'Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study', Blood, vol. 116, no. 21, pp. 1281-1281.

Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study. / Koivula, Satu; Taskinen, Minna; Chen, Ping et al.
In: Blood, Vol. 116, No. 21, 2010, p. 1281-1281.

Research output: Contribution to journal › Published meeting abstract › peer-review

TY - JOUR

T1 - Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

AU - Koivula, Satu

AU - Taskinen, Minna

AU - Chen, Ping

AU - Holte, Harald

AU - Delabie, Jan

AU - Lindsberg, Marja Liisa Karjalainen

AU - Bjorkholm, Magnus

AU - Fluge, Oystein

AU - Pedersen, Lars Moller

AU - Jerkeman, Mats

AU - Eriksson, Mikael

AU - Hautaniemi, Sampsa

AU - Leppa, Sirpa

PY - 2010

Y1 - 2010

M3 - Published meeting abstract

SN - 1528-0020

VL - 116

SP - 1281

EP - 1281

JO - Blood

JF - Blood

IS - 21

T2 - 52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 4 December 2010 through 7 December 2010

ER -

Koivula S, Taskinen M, Chen P, Holte H, Delabie J, Lindsberg MLK et al. Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study. Blood. 2010;116(21):1281-1281.